Satellos Bioscience Inc
- Stock Issuer and Owners
| Due Diligence for Asset Managers |
Analyze the public filings of asset managers
Dive into the EDGAR, IAPD, CAFR source data
|
| Satellos Bioscience Inc |
| Ticker | MSLE |
| CIK # | 0001421642 |
| CUSIP | 80401L803 |
| Sector | Life Sciences - Pharmaceutical Preparations |
| Address | Royal Bank Plaza, S Tower, 200 Bay St Suite 2800, Toronto, ON M5J 2J1 |
| Source |
[EDGAR]
|
| Reg D Offering (Form D) |
Filed |
Raised |
Terms |
| Satellos Bioscience Inc |
2025-01-03 |
25.0 M |
Exemption: 506(b) · Duration: One year or less · Commission: $1,736,980 · Revenue: Decline to Disclose
|
| ICO Therapeutics Inc |
2019-09-10 |
0.2 M |
Exemption: 506(b) · Remaining: $2,323,658 · Duration: More than one year · Revenue: No Revenues
|
| 13F Ownership Over Time | Holders | Shares Held |
| 2026-03-31 |
31 |
7,954,404 |
| Form 13F Holdings |
| Firm |
Period |
DFND |
Voting |
Shares |
Prev | Page 1 | Next
|
{"search": "/search", "clicked": "/clicked", "portfolio_add": "/portfolio-add", "portfolio_remove": "/portfolio-remove", "portfolio_create": "/portfolio-create", "portfolio_activate": "/portfolio-activate", "portfolio_delete": "/portfolio-delete", "portfolio_rename": "/portfolio-rename", "portfolio_color": "/portfolio-color", "home_filter": "/home-filter", "htmlspeed": "/htmlspeed", "add_tag_firm": "/add-tag-firm", "add_tag_click": "/add-tag-click", "copy_aum": "/copy-aum", "stripe_checkout": "/stripe-checkout", "stripe_subscribe": "/stripe-subscribe", "update_card": "/update-card"}
{"uid": 217383038, "pid": -1, "pid_a": [], "name": "", "email": "", "blacklist_f": false, "paywall_f": false, "paywall_n": 2, "random_n": 0.7884073936657114}
False
325852417